Disruption of gene expression and induction of apoptosis in prostate cancer cells by a DNA-damaging agent tethered to an androgen receptor ligand

被引:28
|
作者
Marquis, JC
Hillier, SM
Dinaut, AN
Rodrigues, D
Mitra, K
Essigmann, JM
Croy, RG
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
[2] MIT, Biol Engn Div, Cambridge, MA 02139 USA
来源
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 07期
关键词
D O I
10.1016/j.chembiol.2005.05.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The goal of our work was the design of DNA-damaging agents that disrupt both DNA repair and signaling pathways in prostate tumor cells. A DNA alkylator (N,N-bis-2-chloroethyl aniline) was linked to a steroid ligand (17 beta-hyroxy-estra-Delta(4(5),9(10))-3-one) to produce a complex molecule (11 beta-dichloro) that forms DNA adducts that bind the androgen receptor (AR). We speculated that DNA adducts in an AR-DNA adduct complex would be camouflaged from DNA repair proteins that would otherwise remove the adducts in prostate cancer cells. Furthermore, transcription dependent on the AR would be antagonized by AR redistribution to sites distant from AR-driven promoters. The anticancer potential of 11 beta-dichloro was demonstrated against prostate cancer cells in vitro and in vivo. 11 beta-dichloro induces a unique pattern of gene disruption, induces apoptosis in apoptosis-resistant cells, and shows promising anticancer activity in animals.
引用
收藏
页码:779 / 787
页数:9
相关论文
共 50 条
  • [21] Androgen receptor expression is induced by docetaxel in prostate cancer cells
    Tinzl, M., V
    Chen, B.
    Chen, S.
    Abrahamsson, P. A.
    Dizeyi, N.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E934 - U962
  • [22] Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
    Sharifi, Nima
    Hurt, Elaine M.
    Farrar, William L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 921 - 923
  • [23] Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
    Nima Sharifi
    Elaine M. Hurt
    William L. Farrar
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 921 - 923
  • [24] PSA regulates androgen receptor expression in prostate cancer cells
    Saxena, Parmita
    Trerotola, Marco
    Wang, Tao
    Li, Jing
    Sayeed, Aejaz
    VanOudenhove, Jennifer
    Adams, Dave S.
    FitzGerald, Thomas J.
    Altieri, Dario C.
    Languino, Lucia R.
    PROSTATE, 2012, 72 (07): : 769 - 776
  • [25] EFFECTS OF DNA-DAMAGING AGENTS ON GENE-EXPRESSION IN 2 HUMAN CANCER CELL-LINES
    VIKHANSKAYA, F
    DINCALCI, M
    BROGGINI, M
    CELLULAR AND MOLECULAR BIOLOGY, 1993, 39 (08) : 855 - 862
  • [26] Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells
    Cheung, BW
    Jin, DY
    Ling, MT
    Wong, YC
    Wang, Q
    Tsao, SW
    Wang, XH
    CANCER RESEARCH, 2005, 65 (04) : 1450 - 1458
  • [27] Androgen receptor gene amplification and protein expression in recurrent prostate cancer
    Ford, OH
    Gregory, CW
    Kim, D
    Smitherman, AB
    Mohler, JL
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1817 - 1821
  • [28] Androgen receptor and prostate cancer: Molecular aspects and gene expression profiling
    Sommer, A
    Haendler, B
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (05) : 702 - 711
  • [29] Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer
    Chiu, Helen H. L.
    Yong, Theresa M. K.
    Wang, Jun
    Wang, Yuwei
    Vessella, Robert L.
    Ueda, Takeshi
    Wang, Yu-Zhuo
    Sadar, Marianne D.
    CANCER LETTERS, 2010, 292 (02) : 176 - 185
  • [30] PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells
    Itsumi, Momoe
    Shiota, Masaki
    Yokomizo, Akira
    Takeuchi, Ario
    Kashiwagi, Eiji
    Dejima, Takashi
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Uchiumi, Takeshi
    Naito, Seiji
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2014, 53 (01) : 31 - 41